Graduate Training in Stem Cell Biology and Regenerative Medicine

干细胞生物学和再生医学研究生培训

• 批准号: 9278892
• 负责人: Theo D Palmer
• 金额: $ 23.31万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-01 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9278892
• 关键词: Regenerative Medicine; Training; stem cell biology

PROJECT SUMMARY This new T32 application seeks support for predoctoral training in the newly established doctoral degree program in Stem Cell Biology and Regenerative Medicine (SCBRM) at Stanford University. The SCBRM graduate program is the first new doctoral degree program at the School of Medicine in more than 20 years. The program faculty span multiple schools and departments at Stanford and our primary goal is to train the best scientists in this new discipline through a combination of basic stem cell biology and the role of stem cells in the development, maintenance, and disease pathogenesis of human tissues and organs. Over the last decade, fundamental discoveries in the biomedical and physical sciences have generated a strong climate of expectation that discoveries should and will lead to new medical applications and novel therapies. There is no greater expectation than that produced within the broad discipline of stem cell biology and regenerative medicine, an established area of study that rests squarely on an unprecedented intersection of disciplines. On the one hand, rapid advances in basic biology, genetics, material sciences, nanotechnology, engineering, and physics are providing extraordinary new tools for harnessing stem cells in regenerative medicine. On the other hand, rapid and continued growth of financial investment in translational medicine by national, state, and private entities targets research dollars with an increasing focus on applied science. Research in stem cell biology and regenerative medicine also raises ethical and legal concerns that are unique in all of biological research; thus, this broad intersection of disciplines is producing a new breed of scientist, one with skills that embrace biological and physical sciences, medicine, business, ethics and law. In the following application we outline a novel predoctoral curriculum and training plan that provides a strong foundation in developmental and cellular biology, genetics, and biochemistry. These intellectual strengths are partnered with clinical science, bioengineering, business, ethics and law to produce a new generation of scientist who is both motivated and capable of translating stem cell discoveries into new applications in regenerative medicine.

项目摘要 这一新的T32申请寻求对新设立的博士学位的博士前培训的支持 在干细胞生物学和再生医学（SCBRM）计划在斯坦福大学。SCBRM 研究生课程是20多年来医学院第一个新的博士学位课程。 该计划的教师跨越多个学校和部门在斯坦福大学和我们的主要目标是培养 最好的科学家在这一新的学科通过结合基本的干细胞生物学和干细胞的作用 在人体组织和器官的发育、维持和疾病发病机制中的作用。 在过去的十年里，生物医学和物理科学的基础发现产生了一个 一种强烈的期望气氛，认为这些发现应该并将导致新的医学应用和新的 治疗没有比在干细胞生物学的广泛学科中产生的期望更大的期望了 和再生医学，一个建立在前所未有的交叉点上的研究领域， 纪律。一方面，基础生物学、遗传学、材料科学、纳米技术、 工程学和物理学为利用干细胞再生提供了非凡的新工具。 药另一方面，通过对转化医学的财政投资的快速和持续增长， 国家、州和私人实体将研究资金的目标越来越集中在应用科学上。 干细胞生物学和再生医学的研究也引起了独特的伦理和法律的关注 在所有的生物学研究中，这种广泛的学科交叉正在产生一批新的科学家， 一个拥有生物和物理科学、医学、商业、道德和法律技能的人。 在下面的应用程序中，我们概述了一个新的博士前课程和培训计划，提供了一个强大的 发育和细胞生物学、遗传学和生物化学基础。这些智力优势是 与临床科学，生物工程，商业，道德和法律合作， 一位既有动力又有能力将干细胞发现转化为新应用的科学家， 再生医学